BIOMAT Database Logo BIOMAT Database Logo

External beam and intraluminal radiotherapy in the treatment of carcinoma of the esophagus. 1988

E C Hyden, and B Langholz, and T Tilden, and K Lam, and G Luxton, and M Astrahan, and J Jepson, and Z Petrovich
Department of Radiation Oncology, University of Southern California School of Medicine, Los Angeles.

During a 10-year period, 46 patients with unresectable or inoperable carcinoma of the esophagus were treated with teletherapy-brachytherapy combination at the University of Southern California School of Medicine. Stage distribution was as follows: stage I, 5 (11%) patients; stage II, 23 (50%) patients; stage III, six (13%) patients; and stage IV, 12 (26%) patients. Thirteen patients were treated for recurrent disease, including 11 patients initially treated with teletherapy and two who had had surgical resection. Radiotherapy was given by teletherapy in 33 and brachytherapy in all 46 patients. An average tumor dose was 50 Gy with teletherapy and 20 Gy per application with brachytherapy. There were 25 patients who had more than one brachytherapy application. The 5-year actuarial survival rate for 28 patients with stage I or II disease was 12%, with a median of 13 months. This compared with no 5-year survivals and a median survival of 10 months for the 18 patients with stage III or IV disease. Failure at the primary site was seen in 16 (35%) patients. Complete response was seen in 20%, partial response in 76%, and no response in 4%. Treatment was well tolerated. Complications included esophageal stenosis in two patients and tracheoesophageal fistula in one. Teletherapy-brachytherapy combination is an effective treatment in the management of unresectable or inoperable carcinoma of the esophagus.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011832 Radiation Injuries Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES. Radiation Sickness,Radiation Syndrome,Injuries, Radiation,Injury, Radiation,Radiation Injury,Radiation Sicknesses,Radiation Syndromes,Sickness, Radiation,Sicknesses, Radiation,Syndrome, Radiation,Syndromes, Radiation
D001918 Brachytherapy A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. Curietherapy,Implant Radiotherapy,Plaque Therapy, Radioisotope,Radioisotope Brachytherapy,Radiotherapy, Interstitial,Radiotherapy, Intracavity,Radiotherapy, Surface,Brachytherapy, Radioisotope,Interstitial Radiotherapy,Intracavity Radiotherapy,Radioisotope Plaque Therapy,Radiotherapy, Implant,Surface Radiotherapy,Therapy, Radioisotope Plaque
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E C Hyden, and B Langholz, and T Tilden, and K Lam, and G Luxton, and M Astrahan, and J Jepson, and Z Petrovich
External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma.
February 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
E C Hyden, and B Langholz, and T Tilden, and K Lam, and G Luxton, and M Astrahan, and J Jepson, and Z Petrovich
Treatment of roentogenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low dose rate brachytherapy.
March 1996, International journal of radiation oncology, biology, physics,
E C Hyden, and B Langholz, and T Tilden, and K Lam, and G Luxton, and M Astrahan, and J Jepson, and Z Petrovich
Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors.
December 2002, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
E C Hyden, and B Langholz, and T Tilden, and K Lam, and G Luxton, and M Astrahan, and J Jepson, and Z Petrovich
Treatment of roentgenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low-dose-rate brachytherapy: second report.
June 2000, International journal of radiation oncology, biology, physics,
E C Hyden, and B Langholz, and T Tilden, and K Lam, and G Luxton, and M Astrahan, and J Jepson, and Z Petrovich
External beam radiotherapy in the treatment of prostatic carcinoma: technical procedures.
January 1993, Rays,
E C Hyden, and B Langholz, and T Tilden, and K Lam, and G Luxton, and M Astrahan, and J Jepson, and Z Petrovich
Combined external beam and low dose rate intraluminal radiotherapy in oesophageal cancer.
April 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
E C Hyden, and B Langholz, and T Tilden, and K Lam, and G Luxton, and M Astrahan, and J Jepson, and Z Petrovich
A prospective study of radical external beam radiotherapy versus external beam radiotherapy combined with intraluminal brachytherapy for primary esophageal cancer.
January 2022, Brachytherapy,
E C Hyden, and B Langholz, and T Tilden, and K Lam, and G Luxton, and M Astrahan, and J Jepson, and Z Petrovich
External beam radiotherapy and intraluminal brachytherapy in advanced inoperable esophageal cancer: JIPMER experience.
February 2002, American journal of clinical oncology,
E C Hyden, and B Langholz, and T Tilden, and K Lam, and G Luxton, and M Astrahan, and J Jepson, and Z Petrovich
External beam radiotherapy and intraluminal brachytherapy in advanced inoperable esophageal cancer: JIPMER experience.
April 2001, American journal of clinical oncology,
E C Hyden, and B Langholz, and T Tilden, and K Lam, and G Luxton, and M Astrahan, and J Jepson, and Z Petrovich
External beam radiotherapy for carcinoma of the prostate.
June 1989, Cancer,
Copied contents to your clipboard!